Literature DB >> 4263696

Specific inactivation of the fourth complement component. I. In vivo studies.

J A Jensen, M C Garces, E Iglesias.   

Abstract

Intravascular injection of guinea pigs with the fourth complement component (C4) inactivator from shark serum resulted in severe serum C4 depletion that lasted for several hours. Active and direct passive Arthus reactions did not develop or were extremely mild in such C4 inactivator-treated animals as judged by gross and histological observation. In consideration of the specificity of the C4 inactivator, its independence of cofactors, and its failure to generate biologically active materials in the process of C4 inactivation, it is concluded that complement-dependent immune injury can be suppressed or avoided by interruption of the complement cascade at a single early step. The depression of the Arthus reaction beyond the time of C4 recovery prompted quantitative speculations concerning (i) the in vivo rate of C5a generation under conditions of limited C4 supply and (ii) the "saturation" of immune complexes. This view is supported by in vitro demonstration of functional inactivation or "saturation" of immune precipitates by repeated incubation with fresh guinea pig complement. It seems therefore conceivable that even temporary complement inactivation may have a profound beneficial effect on complement-dependent immune injuries.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4263696      PMCID: PMC416256          DOI: 10.1128/iai.4.1.12-19.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

Review 1.  Immunologic tissue injury mediated by neutrophilic leukocytes.

Authors:  C G Cochrane
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

2.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

Review 3.  Mediators of the arthus and related reactions.

Authors:  C G Cochrane
Journal:  Prog Allergy       Date:  1967

4.  Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.

Authors:  H S Shin; R Snyderman; E Friedman; A Mellors; M M Mayer
Journal:  Science       Date:  1968-10-18       Impact factor: 47.728

5.  Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

Authors:  R J Pickering; M R Wolfson; R A Good; H Gewurz
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

6.  Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes.

Authors:  H S Shin; H Gewurz; R Snyderman
Journal:  Proc Soc Exp Biol Med       Date:  1969-05

7.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

8.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

9.  Anaphylatoxin in its relation to the complement system.

Authors:  J Jensen
Journal:  Science       Date:  1967-03-03       Impact factor: 47.728

10.  A specific inactivator of mammalian C'4 isolated from nurse shark (Ginglymostoma cirratum) serum.

Authors:  J A Jensen
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

View more
  3 in total

1.  Opsonization of Listeria monocytogenes type 4b by human adult and newborn sera.

Authors:  R Bortolussi; A Issekutz; G Faulkner
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

Review 2.  Immunological concepts and the eye: a review of the classical and ocular arthus reactions.

Authors:  L D Ormerod
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

3.  Specific inactivation of the fourth complement component. II. In vitro studies.

Authors:  M C Garces; J A Jensen; E Iglesias
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.